KKL MED is one of the world's leading suppliers of high-performance life science products, covering 30 popular research fields such as cancer, neuroscience, anti-infection, epigenetics, etc., covering nearly 1,000 niche targets such as Akt, Jak, etc. KKL MED currently provides more than 80,000 chemical small molecules and peptides, including neurotransmitters, ion pathways and signal inhibitors, etc., for life science research. KKL MED is an expert in inhibitors for the life sciences, with products of excellent purity, stability and biological activity. KKL MED's mission is to make the most innovative life science reagents more accessible to scientists around the world and to help them make major scientific discoveries faster. These compounds have a wide range of applications in preclinical research of human diseases and have a wide range of potential uses. All KKL MED products may only be used for research use only and are strictly prohibited for medical purposes in humans or animals.
